nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CHRNA4—autonomic nervous system—conduct disorder	0.0461	0.396	CbGeAlD
Phenobarbital—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.0408	0.0556	CbGpPWpGaD
Phenobarbital—Quinidine barbiturate—GABRA2—conduct disorder	0.0274	0.184	CrCbGaD
Phenobarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0268	0.0365	CbGpPWpGaD
Phenobarbital—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.025	0.034	CbGpPWpGaD
Phenobarbital—GRIA2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0197	0.0269	CbGpPWpGaD
Phenobarbital—Heptabarbital—GABRA2—conduct disorder	0.0172	0.115	CrCbGaD
Phenobarbital—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0154	0.021	CbGpPWpGaD
Phenobarbital—Butethal—GABRA2—conduct disorder	0.0149	0.0999	CrCbGaD
Phenobarbital—Aprobarbital—GABRA2—conduct disorder	0.0143	0.0962	CrCbGaD
Phenobarbital—CYP4B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0142	0.0193	CbGpPWpGaD
Phenobarbital—Amobarbital—GABRA2—conduct disorder	0.0138	0.0929	CrCbGaD
Phenobarbital—Primidone—GABRA2—conduct disorder	0.0138	0.0926	CrCbGaD
Phenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0133	0.0181	CbGpPWpGaD
Phenobarbital—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.0133	0.018	CbGpPWpGaD
Phenobarbital—Methylphenobarbital—GABRA2—conduct disorder	0.0129	0.0869	CrCbGaD
Phenobarbital—Secobarbital—GABRA2—conduct disorder	0.0123	0.0828	CrCbGaD
Phenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0121	0.0164	CbGpPWpGaD
Phenobarbital—Pentobarbital—GABRA2—conduct disorder	0.0116	0.0781	CrCbGaD
Phenobarbital—Talbutal—GABRA2—conduct disorder	0.0107	0.0717	CrCbGaD
Phenobarbital—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0105	0.0142	CbGpPWpGaD
Phenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0102	0.0138	CbGpPWpGaD
Phenobarbital—GRIK2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00998	0.0136	CbGpPWpGaD
Phenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00985	0.0134	CbGpPWpGaD
Phenobarbital—CYP1A2—Methylation—COMT—conduct disorder	0.0097	0.0132	CbGpPWpGaD
Phenobarbital—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.00951	0.0129	CbGpPWpGaD
Phenobarbital—CYP4B1—brain—conduct disorder	0.0092	0.079	CbGeAlD
Phenobarbital—CHRNA7—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00908	0.0124	CbGpPWpGaD
Phenobarbital—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.00773	0.0105	CbGpPWpGaD
Phenobarbital—GRIK2—Neuronal System—GABRA2—conduct disorder	0.00765	0.0104	CbGpPWpGaD
Phenobarbital—GRIA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00763	0.0104	CbGpPWpGaD
Phenobarbital—CYP4B1—Biological oxidations—COMT—conduct disorder	0.00757	0.0103	CbGpPWpGaD
Phenobarbital—CYP4B1—Biological oxidations—MAOA—conduct disorder	0.00752	0.0102	CbGpPWpGaD
Phenobarbital—CYP4B1—Metapathway biotransformation—COMT—conduct disorder	0.00747	0.0102	CbGpPWpGaD
Phenobarbital—CHRNA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0074	0.0101	CbGpPWpGaD
Phenobarbital—CYP4A11—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00736	0.01	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00704	0.00958	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—GABRA2—conduct disorder	0.00696	0.00947	CbGpPWpGaD
Phenobarbital—SLCO2A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00656	0.00893	CbGpPWpGaD
Phenobarbital—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00645	0.00877	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00644	0.00877	CbGpPWpGaD
Phenobarbital—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00643	0.00876	CbGpPWpGaD
Phenobarbital—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.00627	0.00854	CbGpPWpGaD
Phenobarbital—GRIA2—brain—conduct disorder	0.00614	0.0527	CbGeAlD
Phenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0061	0.0083	CbGpPWpGaD
Phenobarbital—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00606	0.00825	CbGpPWpGaD
Phenobarbital—CYP4A11—NRF2 pathway—SLC6A4—conduct disorder	0.00592	0.00806	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—GABRA2—conduct disorder	0.00585	0.00796	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00574	0.00781	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—GABRA2—conduct disorder	0.00567	0.00772	CbGpPWpGaD
Phenobarbital—CHRFAM7A—brain—conduct disorder	0.00559	0.048	CbGeAlD
Phenobarbital—GRIK2—brain—conduct disorder	0.00554	0.0476	CbGeAlD
Phenobarbital—SLCO2A1—brain—conduct disorder	0.0055	0.0473	CbGeAlD
Phenobarbital—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.00542	0.00738	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00529	0.00721	CbGpPWpGaD
Phenobarbital—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00528	0.00718	CbGpPWpGaD
Phenobarbital—ABCC3—NRF2 pathway—SLC6A4—conduct disorder	0.00504	0.00686	CbGpPWpGaD
Phenobarbital—GRIK2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0048	0.00654	CbGpPWpGaD
Phenobarbital—GRIK2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00477	0.00649	CbGpPWpGaD
Phenobarbital—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00474	0.00646	CbGpPWpGaD
Phenobarbital—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00468	0.00637	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00458	0.00624	CbGpPWpGaD
Phenobarbital—CHRNA7—brain—conduct disorder	0.00452	0.0388	CbGeAlD
Phenobarbital—CYP2A6—brain—conduct disorder	0.00451	0.0388	CbGeAlD
Phenobarbital—CHRNA4—brain—conduct disorder	0.00445	0.0383	CbGeAlD
Phenobarbital—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.00439	0.00598	CbGpPWpGaD
Phenobarbital—CHRNA7—Transmission across Chemical Synapses—COMT—conduct disorder	0.00437	0.00595	CbGpPWpGaD
Phenobarbital—CHRNA7—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00434	0.00591	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00432	0.00587	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00432	0.00587	CbGpPWpGaD
Phenobarbital—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00428	0.00582	CbGpPWpGaD
Phenobarbital—ABCC3—brain—conduct disorder	0.00423	0.0363	CbGeAlD
Phenobarbital—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00411	0.00559	CbGpPWpGaD
Phenobarbital—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00399	0.00544	CbGpPWpGaD
Phenobarbital—CYP4A11—Biological oxidations—COMT—conduct disorder	0.00394	0.00536	CbGpPWpGaD
Phenobarbital—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00392	0.00534	CbGpPWpGaD
Phenobarbital—CYP4A11—Biological oxidations—MAOA—conduct disorder	0.00391	0.00532	CbGpPWpGaD
Phenobarbital—GABRA1—brain—conduct disorder	0.00385	0.0331	CbGeAlD
Phenobarbital—GRIK2—Neuronal System—COMT—conduct disorder	0.00368	0.00501	CbGpPWpGaD
Phenobarbital—GRIA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00367	0.005	CbGpPWpGaD
Phenobarbital—GRIK2—Neuronal System—MAOA—conduct disorder	0.00365	0.00497	CbGpPWpGaD
Phenobarbital—GRIA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00365	0.00496	CbGpPWpGaD
Phenobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00356	0.00485	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00355	0.00483	CbGpPWpGaD
Phenobarbital—CHRNA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00354	0.00482	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00352	0.00479	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—GABRA2—conduct disorder	0.00351	0.00478	CbGpPWpGaD
Phenobarbital—CYP2C18—Biological oxidations—COMT—conduct disorder	0.00344	0.00469	CbGpPWpGaD
Phenobarbital—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.00342	0.00465	CbGpPWpGaD
Phenobarbital—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.0034	0.00462	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00335	0.00456	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—COMT—conduct disorder	0.00335	0.00456	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—MAOA—conduct disorder	0.00333	0.00453	CbGpPWpGaD
Phenobarbital—CYP1B1—brain—conduct disorder	0.00331	0.0284	CbGeAlD
Phenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00316	0.00431	CbGpPWpGaD
Phenobarbital—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00316	0.00429	CbGpPWpGaD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00313	0.00425	CbGpPWpGaD
Phenobarbital—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00313	0.00425	CbGpPWpGaD
Phenobarbital—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0031	0.00422	CbGpPWpGaD
Phenobarbital—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00309	0.00421	CbGpPWpGaD
Phenobarbital—ABCC1—brain—conduct disorder	0.00297	0.0256	CbGeAlD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00297	0.00404	CbGpPWpGaD
Phenobarbital—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00292	0.00398	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—CGA—conduct disorder	0.00287	0.0039	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00285	0.00388	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—COMT—conduct disorder	0.00281	0.00383	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—MAOA—conduct disorder	0.00279	0.0038	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—COMT—conduct disorder	0.00273	0.00372	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—MAOA—conduct disorder	0.00271	0.00369	CbGpPWpGaD
Phenobarbital—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00268	0.00365	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00267	0.00364	CbGpPWpGaD
Phenobarbital—ABCC3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00254	0.00346	CbGpPWpGaD
Phenobarbital—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00254	0.00345	CbGpPWpGaD
Phenobarbital—CYP2C8—brain—conduct disorder	0.00253	0.0218	CbGeAlD
Phenobarbital—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00252	0.00343	CbGpPWpGaD
Phenobarbital—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.0025	0.00341	CbGpPWpGaD
Phenobarbital—CYP4A11—PPARA activates gene expression—EP300—conduct disorder	0.00241	0.00329	CbGpPWpGaD
Phenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00239	0.00325	CbGpPWpGaD
Phenobarbital—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00236	0.00322	CbGpPWpGaD
Phenobarbital—CYP1A1—brain—conduct disorder	0.00234	0.0201	CbGeAlD
Phenobarbital—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00229	0.00311	CbGpPWpGaD
Phenobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00229	0.00311	CbGpPWpGaD
Phenobarbital—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00227	0.00309	CbGpPWpGaD
Phenobarbital—CYP2B6—brain—conduct disorder	0.00227	0.0195	CbGeAlD
Phenobarbital—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00226	0.00307	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00223	0.00304	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00221	0.003	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00219	0.00298	CbGpPWpGaD
Phenobarbital—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00218	0.00297	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00218	0.00296	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00216	0.00294	CbGpPWpGaD
Phenobarbital—CYP2E1—brain—conduct disorder	0.00213	0.0183	CbGeAlD
Phenobarbital—CYP2A6—Biological oxidations—COMT—conduct disorder	0.0021	0.00285	CbGpPWpGaD
Phenobarbital—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00208	0.00283	CbGpPWpGaD
Phenobarbital—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00201	0.00274	CbGpPWpGaD
Phenobarbital—ABCC1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00199	0.00271	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00193	0.00262	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00193	0.00262	CbGpPWpGaD
Phenobarbital—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00189	0.00257	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00186	0.00254	CbGpPWpGaD
Phenobarbital—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00186	0.00254	CbGpPWpGaD
Phenobarbital—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.0017	0.00232	CbGpPWpGaD
Phenobarbital—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00169	0.0023	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—COMT—conduct disorder	0.00169	0.0023	CbGpPWpGaD
Phenobarbital—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00168	0.00229	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—MAOA—conduct disorder	0.00168	0.00228	CbGpPWpGaD
Phenobarbital—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00167	0.00227	CbGpPWpGaD
Phenobarbital—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00166	0.00226	CbGpPWpGaD
Phenobarbital—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00165	0.00225	CbGpPWpGaD
Phenobarbital—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.00165	0.00224	CbGpPWpGaD
Phenobarbital—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00164	0.00224	CbGpPWpGaD
Phenobarbital—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00163	0.00223	CbGpPWpGaD
Phenobarbital—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00163	0.00222	CbGpPWpGaD
Phenobarbital—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00163	0.00222	CbGpPWpGaD
Phenobarbital—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00156	0.00213	CbGpPWpGaD
Phenobarbital—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00155	0.00211	CbGpPWpGaD
Phenobarbital—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00154	0.0021	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—CGA—conduct disorder	0.00149	0.00203	CbGpPWpGaD
Phenobarbital—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00144	0.00196	CbGpPWpGaD
Phenobarbital—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00143	0.00195	CbGpPWpGaD
Phenobarbital—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00142	0.00194	CbGpPWpGaD
Phenobarbital—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00141	0.00192	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00133	0.00181	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—CGA—conduct disorder	0.00132	0.0018	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—CGA—conduct disorder	0.0013	0.00177	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—COMT—conduct disorder	0.0013	0.00176	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—MAOA—conduct disorder	0.00129	0.00175	CbGpPWpGaD
Phenobarbital—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00128	0.00174	CbGpPWpGaD
Phenobarbital—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00127	0.00173	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CGA—conduct disorder	0.00127	0.00173	CbGpPWpGaD
Phenobarbital—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00126	0.00172	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00125	0.0017	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00123	0.00167	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00123	0.00167	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00122	0.00166	CbGpPWpGaD
Phenobarbital—ABCB1—brain—conduct disorder	0.00121	0.0104	CbGeAlD
Phenobarbital—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00117	0.00159	CbGpPWpGaD
Phenobarbital—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00116	0.00158	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00115	0.00157	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00115	0.00157	CbGpPWpGaD
Phenobarbital—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00115	0.00157	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00109	0.00148	CbGpPWpGaD
Phenobarbital—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000997	0.00136	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CGA—conduct disorder	0.000994	0.00135	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000992	0.00135	CbGpPWpGaD
Phenobarbital—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000989	0.00135	CbGpPWpGaD
Phenobarbital—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000983	0.00134	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CGA—conduct disorder	0.000961	0.00131	CbGpPWpGaD
Phenobarbital—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.000958	0.0013	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000947	0.00129	CbGpPWpGaD
Phenobarbital—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.000938	0.00128	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CGA—conduct disorder	0.000867	0.00118	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000848	0.00115	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CGA—conduct disorder	0.000795	0.00108	CbGpPWpGaD
Phenobarbital—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000769	0.00105	CbGpPWpGaD
Phenobarbital—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000764	0.00104	CbGpPWpGaD
Phenobarbital—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000759	0.00103	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—COMT—conduct disorder	0.000674	0.000917	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—MAOA—conduct disorder	0.000669	0.00091	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000649	0.000883	CbGpPWpGaD
Phenobarbital—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000646	0.00088	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CGA—conduct disorder	0.000641	0.000873	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CGA—conduct disorder	0.000628	0.000855	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CGA—conduct disorder	0.000627	0.000853	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—COMT—conduct disorder	0.000597	0.000813	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—MAOA—conduct disorder	0.000593	0.000807	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CGA—conduct disorder	0.000592	0.000806	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—COMT—conduct disorder	0.000589	0.000801	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—MAOA—conduct disorder	0.000585	0.000796	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000575	0.000783	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—COMT—conduct disorder	0.000573	0.000779	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—MAOA—conduct disorder	0.000569	0.000774	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—EP300—conduct disorder	0.000555	0.000756	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000551	0.000751	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CGA—conduct disorder	0.000543	0.000739	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000492	0.00067	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CGA—conduct disorder	0.000485	0.000659	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CGA—conduct disorder	0.000473	0.000644	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—COMT—conduct disorder	0.000449	0.000611	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—MAOA—conduct disorder	0.000446	0.000606	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CGA—conduct disorder	0.000442	0.000601	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—COMT—conduct disorder	0.000434	0.000591	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000432	0.000588	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—MAOA—conduct disorder	0.000431	0.000587	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000418	0.000569	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—COMT—conduct disorder	0.000391	0.000533	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—MAOA—conduct disorder	0.000389	0.000529	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CGA—conduct disorder	0.000378	0.000514	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—COMT—conduct disorder	0.000359	0.000488	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—MAOA—conduct disorder	0.000356	0.000485	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CGA—conduct disorder	0.000291	0.000397	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—COMT—conduct disorder	0.000289	0.000394	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—EP300—conduct disorder	0.000289	0.000393	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—MAOA—conduct disorder	0.000287	0.000391	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—COMT—conduct disorder	0.000283	0.000386	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—COMT—conduct disorder	0.000283	0.000385	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—MAOA—conduct disorder	0.000281	0.000383	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—MAOA—conduct disorder	0.000281	0.000382	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—COMT—conduct disorder	0.000267	0.000364	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—MAOA—conduct disorder	0.000265	0.000361	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000257	0.00035	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—EP300—conduct disorder	0.000256	0.000349	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—EP300—conduct disorder	0.000252	0.000344	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—EP300—conduct disorder	0.000246	0.000334	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—COMT—conduct disorder	0.000245	0.000333	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—MAOA—conduct disorder	0.000243	0.000331	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000236	0.000321	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EP300—conduct disorder	0.00023	0.000313	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—COMT—conduct disorder	0.000219	0.000298	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—MAOA—conduct disorder	0.000217	0.000296	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—COMT—conduct disorder	0.000213	0.000291	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—MAOA—conduct disorder	0.000212	0.000288	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000211	0.000287	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—COMT—conduct disorder	0.000199	0.000271	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—MAOA—conduct disorder	0.000198	0.00027	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—EP300—conduct disorder	0.000192	0.000262	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000192	0.000261	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—EP300—conduct disorder	0.000186	0.000253	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—COMT—conduct disorder	0.00017	0.000232	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—MAOA—conduct disorder	0.000169	0.00023	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—EP300—conduct disorder	0.000168	0.000228	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000164	0.000223	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—EP300—conduct disorder	0.000154	0.000209	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—COMT—conduct disorder	0.000132	0.000179	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—MAOA—conduct disorder	0.000131	0.000178	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—EP300—conduct disorder	0.000124	0.000169	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—EP300—conduct disorder	0.000122	0.000165	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—EP300—conduct disorder	0.000121	0.000165	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—EP300—conduct disorder	0.000115	0.000156	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—EP300—conduct disorder	0.000105	0.000143	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—EP300—conduct disorder	9.38e-05	0.000128	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—EP300—conduct disorder	9.15e-05	0.000125	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—EP300—conduct disorder	8.55e-05	0.000116	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—EP300—conduct disorder	7.31e-05	9.95e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—EP300—conduct disorder	5.64e-05	7.68e-05	CbGpPWpGaD
